Activation of LA-N-2 Cell Phospholipase D by Amyloid Beta Protein (25–35)

    loading  Checking for direct PDF access through Ovid


Amyloid β protein is the major protein component of neuritic plaques found in the brain of Alzheimer's disease. The activation of phospholipase D by amyloid beta protein (25–35), quisqualate and phorbol 12, 13-dibutyrate was investigated in LA-N-2 cells by measuring phosphatidylethanol formation. The activation of phospholipase D by quisqualate and AβP (25–35) was calcium-independent. The AβP (25–35) and quisqualate activation of phospholipase D appeared to be mediated through a pertussis toxin-sensitive GTP-binding protein. Phospholipase D activation by AβP (25–35), quisqualate and phorbol dibutyrate was not blunted by the protein kinase C inhibitors, staurosporine, H-7 and RO-31-8220. However, it was abolished by overnight exposure to phorbol dibutyrate. This activation of phospholipase D was prevented by the tyrosine kinase inhibitor, genistein but not by tyrophostin A. Several excitatory amino acid antagonists were tested for their ability to prevent the phospholipase D activation by quisqualate and AβP (25–35). Only NBQX was effective with an IC50 of 75 μM for AβP (25–35) and quisqualate. Activation of phospholipase D by AβP or quisqualate was absent in LA-N-2 cells previously desensitized by quisqualate or AβP (25–35), but the activation by phorbol dibutyrate was unaltered. The responsiveness to AβP and quisqualate in previously desensitized cells reappeared subsequent to a period of resensitization. The observations with the antagonist NBQX, and the desensitization and resensitization experiments, are consistent with a receptor occupancy mediated activation of phospholipase D by quisqualate and by AβP (25–35).

Related Topics

    loading  Loading Related Articles